The 25th Congress of the European Hematology Association (EHA) 2020, 11–21 June, will see hematology experts from around the globe congregate online for a spectacular show of the latest research outputs.
Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more was showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.
